121 related articles for article (PubMed ID: 5671226)
1. Metal complexes of 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazone) and related ligands as antitumor agents.
Van Giessen GJ; Petering HG
J Med Chem; 1968 Jul; 11(4):695-9. PubMed ID: 5671226
[No Abstract] [Full Text] [Related]
2. The antitumor activity of Cu(II)KTS, the copper (II) chelate of 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazone).
Crim JA; Petering HG
Cancer Res; 1967 Jul; 27(7):1278-85. PubMed ID: 4952520
[No Abstract] [Full Text] [Related]
3. The effect of dietary mineral supplements of the rat on the antitumor activity of 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazone).
Petering HG; Buskirk HH; Crim JA
Cancer Res; 1967 Jun; 27(6):1115-21. PubMed ID: 6027202
[No Abstract] [Full Text] [Related]
4. Effect of heavy metals on the in vitro cytotoxicity of 3-ethoxy-2-oxobutyraldehyde bis (thiosemicarbazone) and related compounds.
Van Giessen GJ; Crim JA; Petering DH; Petering HG
J Natl Cancer Inst; 1973 Jul; 51(1):139-46. PubMed ID: 4720869
[No Abstract] [Full Text] [Related]
5. Concerning the role of zinc in the antitumor activity of 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazonato) zinc(II) and related chelates.
Petering DH
Biochem Pharmacol; 1974 Feb; 23(3):567-76. PubMed ID: 4207164
[No Abstract] [Full Text] [Related]
6. The effect of B vitamin and protein intake of the rat on the antitumor activity of 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazone).
Crim JA; Buskirk HH; Petering HG
Cancer Res; 1967 Jun; 27(6):1109-14. PubMed ID: 6027201
[No Abstract] [Full Text] [Related]
7. Stability of pyruvaldehyde bis(thiosemicarbazone) and its copper chelate.
Cappuccino JG; Arakawa M; Balis ME
J Med Chem; 1968 Mar; 11(2):399-401. PubMed ID: 5663645
[No Abstract] [Full Text] [Related]
8. Activity of combinations of uracil mustard (NSC-34462) and 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazone) [KTS; NSC-82116] against murine tumors.
Petering HG; Buskirk HH; Crim JA
Cancer Chemother Rep; 1966 Nov; 50(8):557-64. PubMed ID: 5978728
[No Abstract] [Full Text] [Related]
9. The effect of copper and other metal ions on the antitumor activity of pyruvaldehyde bis(thiosemicarbazone).
Cappuccino JG; Banks S; Brown G; George M; Tarnowski GS
Cancer Res; 1967 May; 27(5):968-73. PubMed ID: 6025260
[No Abstract] [Full Text] [Related]
10. Comparative cytotoxic and biochemical effects of ligands and metal complexes of alpha-N-heterocyclic carboxaldehyde thiosemicarbazones.
Saryan LA; Ankel E; Krishnamurti C; Petering DH; Elford H
J Med Chem; 1979 Oct; 22(10):1218-21. PubMed ID: 513069
[TBL] [Abstract][Full Text] [Related]
11. The crystal structure of the natitumor agent 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazonato) Copper(II).
Taylor MR; Glusker JP; Gabe EJ; Minkin JA
Bioinorg Chem; 1974 Apr; 3(3):189-205. PubMed ID: 4418451
[No Abstract] [Full Text] [Related]
12. Free metal ion depletion by "Good's" buffers. I. N-(2-acetamido)iminodiacetic acid 1:1 complexes with calcium(ii). magnesium(II), zinc(II), manganese(II), cobalt(II), nickel(II), and copper(II).
Nakon R
Anal Biochem; 1979 Jun; 95(2):527-32. PubMed ID: 453538
[No Abstract] [Full Text] [Related]
13. Studies on the mode of action of the copper(II)chelate of 2-keto-3-ethoxybutyraldehyde-bis(thiosemicarbazone).
Bhuyan BK; Betz T
Cancer Res; 1968 Apr; 28(4):758-63. PubMed ID: 5649064
[No Abstract] [Full Text] [Related]
14. Topochemistry of trace metals in nasal mucosa. Potentialities of some histochemical methods and energy dispersive X-ray microanalysis.
Torjussen W; Haug FM; Olsen A; Andersen I
Acta Histochem; 1978; 63(1):11-25. PubMed ID: 105552
[TBL] [Abstract][Full Text] [Related]
15. [Analytical studies on thiopyrazolone derivatives. XI. Solvent extraction of metal ions with thiopyrine and its application to the chelatometric titration].
Tanaka T
Yakugaku Zasshi; 1972 Nov; 92(11):1435-40. PubMed ID: 4675513
[No Abstract] [Full Text] [Related]
16. THE ANTI-TUMOR ACTIVITY OF 2-KETO-3-ETHOXYBUTYRALDEHYDE BIS(THIOSEMICARBAZONE) AND RELATED COMPOUNDS.
PETERING HG; BUSKIRK HH; UNDERWOOD GE
Cancer Res; 1964 Apr; 24():367-72. PubMed ID: 14147809
[No Abstract] [Full Text] [Related]
17. Crystal structures, spectroscopic properties of new cobalt(II), nickel(II), zinc(II) and palladium(II) complexes derived from 2-acetyl-5-chloro thiophene thiosemicarbazone: Anticancer evaluation.
Şen B; Kalhan HK; Demir V; Güler EE; Kayalı HA; Subaşı E
Mater Sci Eng C Mater Biol Appl; 2019 May; 98():550-559. PubMed ID: 30813058
[TBL] [Abstract][Full Text] [Related]
18. Metal content of cysteamine oxygenase.
Cavallini D; Duprè S; Scandurra R; Graziani MT; Cotta-Rasusino F
Eur J Biochem; 1968 Apr; 4(2):209-12. PubMed ID: 5655497
[No Abstract] [Full Text] [Related]
19. Exploiting Cancer Metal Metabolism using Anti-Cancer Metal- Binding Agents.
Merlot AM; Kalinowski DS; Kovacevic Z; Jansson PJ; Sahni S; Huang ML; Lane DJR; Lok H; Richardson DR
Curr Med Chem; 2019; 26(2):302-322. PubMed ID: 28685681
[TBL] [Abstract][Full Text] [Related]
20. Novel thiosemicarbazones of the ApT and DpT series and their copper complexes: identification of pronounced redox activity and characterization of their antitumor activity.
Jansson PJ; Sharpe PC; Bernhardt PV; Richardson DR
J Med Chem; 2010 Aug; 53(15):5759-69. PubMed ID: 20597487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]